<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1212246410
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2001
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CIPROCIN 0.3%
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CIPROFLOXACIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        3
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Topical
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Ear/eye drops, solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        13.15
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="RIYADH PHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 407]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S03AA07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>CIPROCIN belongs to a group of medicines known as quinolone antibiotics. It is used for the treatment of corneal ulcers and some other bacterial infections of the eye(s). CIPROCIN contains ciprofloxacin,a quinolone antibiotic that is effective against many of the types of germs that cause bacterial infection in your ear( s ). It is used to treat acute infections of the outer ear (otitis externa or &ldquo;swimmer&rsquo;s ear&rdquo;).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use CIPROCIN </strong></p><p>&bull; If you are allergic (hypersensitive) to ciprofloxacin or any other quinolone antibiotic or to any of the other ingredients listed in section 6. Ask your doctor for advice.</p><p>&bull; Only use CIPROCIN in children younger than 1 year if explicitly prescribed by your doctor.</p><p><strong>Take special care</strong> ...</p><p>- Only use CIPROCIN in your eyes or ears.</p><p>- As with any antibiotic, use of CIPROCIN for a long time may lead to other infections. If your symptoms get worse or suddenly return tell your doctor. You may become more susceptible to other infections with the use of this medicine, especially after prolonged use.</p><p>- If you notice the first signs of a skin rash or any other allergic reaction, including hives, itching, breathing problems stop treatment and immediately contact your doctor. If you have a serious allergic reaction then you may need emergency treatment. - If you feel pain, swelling or inflammation while or shortly after taking this medicine, stop treatment and contact your doctor.</p><p>- If you are elderly or if you are taking medicines called &lsquo;corticosteroids&rsquo; used to treat conditions such as pain and inflammation, asthma or skin problems then you have a higher risk of getting tendon problems during treatment with CIPROCIN. If you experience any inflammation or inflammatory condition, stop treatment and immediately consult your doctor.</p><p>- Avoid excessive sunlight while using CIPROCIN.</p><p><strong>Pregnancy and breast-feeding </strong></p><p>If you are pregnant or might get pregnant, or if you are breast-feeding a baby, talk to your doctor before you use CIPROCIN.</p><p><strong>Driving and using machines</strong></p><p>If your sight is temporarily blurred or affected in any way following use of CIPROCIN <strong>you should not drive or operate machinery until your vision is clear again.</strong></p><p><strong>Using other medicines </strong></p><p>Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. If you are using more than one type of eye medicine, the medicines must be used at least 5 minutes apart. Eye ointments should be used last.</p><p><strong>Important information if you wear Contact Lenses </strong></p><p>There is a preservative in CIPROCIN (benzalkonium chloride) that may cause eye irritation and can discolour soft contact lenses. Do not wear contact lenses (hard or soft) during treatment with CIPROCIN. If you do continue to wear your lenses, you must remove them before using CIPROCIN and wait at least 15 minutes after use before putting your lenses back in.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use CIPROCIN exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure</p><p><strong>Corneal Ulcers</strong></p><p>Dosing is <strong>continued during the night time</strong>. Day 1 - 2 drops every 15 minutes for the first 6 hours and<strong> then </strong>2 drops every 30 minutes.</p><p>Day 2 - 2 drops every hour.</p><p>Day 3 to Day 14 - 2 drops every 4 hours.</p><p>Your doctor will tell you if treatment needs to be continued for longer than 14 days.</p><p><strong>Other bacterial infections</strong></p><p>1 or 2 drops 4 times a day. For severe infections the dose for the first 2 days may be increased to 1 or 2 drops every 2 hours, while you are awake.</p><p>It is important that you <strong>continue to use</strong> CIPROCIN for the<strong> full treatment period</strong> as advised by your doctor even if your symptoms improve. If you stop using this medicine too early, your symptoms may re-occur.</p><p><strong>You should not use </strong>CIPROCIN for <strong>more than 21 days,</strong> unless your doctor says otherwise.</p><p><strong>Remove the loose collar </strong>from the cap when the bottle is first opened.</p><p>Always use CIPROCIN exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure</p><p><strong>Otic use:</strong></p><p><strong>The usual dose</strong></p><p><strong>Adults: </strong>4 drops in the ear canal, twice a day - morning and evening.</p><p><strong>Children</strong> ( over 1 year of age ) :3 drops in the ear canal, twice a day - morning and evening.</p><p>Remove the loose collar from the cap when the bottle is first opened.</p><p>Your doctor will tell you how long your treatment with CIPROCIN will last. To make sure that the infection does not return, do not stop treatment early, even if your ear( s ) feel better.</p><p>As with any antibiotic, use of CIPROCIN for a longer time than advised may lead to other infections.</p><p>Only use CIPROCIN in both ears if your doctor told you to. Always use CIPROCIN exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p><strong>General Instructions </strong></p><ul><li>Wash your hands before you start.</li><li>Twist off the bottle cap.</li><li>Hold the bottle pointing down, between your thumb and fingers.</li></ul><p><strong>How to use for your eyes: </strong></p><ul><li>Tilt your head back.</li><li>Pull down your lower eyelid with a finger, until there is a &#39;pocket&#39; between the eyelid and your eye. The drop will go in here.</li><li>Bring the bottle tip close to the eye.</li><li>Do this in front of a mirror if it helps</li><li><strong>Do not touch your eye or eyelid, </strong>surrounding areas or other surfaces with the dropper. It could infect the drops.</li><li><strong>Gently press</strong> <strong>on the base</strong> of the bottle to release one drop at a time.</li><li><strong>Do not squeeze the bottle, </strong>only a gentle press on the bottom is needed.</li><li>If you use drops in both eyes, repeat the steps for your other eye. Put the bottle cap firmly back on immediately after use.</li><li><strong>If a drop misses your eye,</strong> try again.</li></ul><p><strong>If you forget to use CIPROCIN, </strong>do not worry; just use it when it is next due. <strong>Do not take a double dose to make up. </strong></p><p><strong>If you use more CIPROCIN than you should, </strong>it can be washed out of your eye with lukewarm water.</p><p><strong>If this medicine is accidentally swallowed,</strong> it is <strong>not likely </strong>to cause any serious problems, but contact your doctor.</p><p><strong>How to use for your ears:</strong></p><ul><li>Lie down on your side with the infected ear facing up.</li><li>Bring the bottle tip close to the ear canal.&nbsp;</li><li>Do not touch the fingers, the ear, or any other surfaces with the tip of the bottle as it could infect the drops.</li><li>Gently press on the base of the bottle to release one drop of CIPROCIN at a time.</li><li>Do not squeeze the bottle. A gentle press on the bottom is all that it needs.</li><li>Stay on side - The patient should remain on his / her side for at least five minutes to help penetration of the drops into the ear.&nbsp;</li><li>If both of your ears are infected, repeat the steps for the other ear.</li><li>Put the bottle cap back on firmly immediately after use</li></ul><p><strong>If you have any further questions</strong> on the use of CIPROCIN, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, CIPROCIN can cause side effects, although not everybody gets them.</p><p><strong>You may experience some or all of the following effects in your eye(s): </strong></p><p><em><strong>Common </strong></em>(1 to 10 users in 100): White deposits on the eye surface (cornea), discomfort (stinging or burning, gritty feeling in the eye, irritation), redness.</p><p><em><strong>Uncommon</strong></em> (1 to 10 users in 1,000): Damage to the eye surface (cornea), sensitivity to light, blurred vision, swelling of the eye or eyelid, pain, dry eye, itchiness, eye discharge, eyelid crusting, eyelids scales, eyelid redness, poor vision, watery eyes, red eyes</p><p><em><strong>Rare</strong></em> (1 to 10 users in 10,000): Damage of the eye, inflammation, double vision, decreased eye sensation, tired eyes, stye.</p><p><strong>If you notice white particles in your eyes, </strong>continue to use CIPROCIN but tell your doctor immediately.</p><p>- You may also experience effects in other areas of your body including:</p><p><em><strong>Common:</strong></em> Bad taste.</p><p><em><strong>Uncommon: </strong></em>Headache, nausea.</p><p><strong>Rare: </strong>Hypersensitivity, dizziness, ear pain, inflammation inside the nose, nasal sinus discharge, diarrhoea, abdominal pain, skin inflammation, tendon disorder.</p><p><strong>You may experience some or all of the following effects in your ear(s):</strong></p><p><em><strong>Uncommon </strong></em>(affect 1 to 10 people in 1000): Pain, congestion,&nbsp;weeping ear, itching, ringing in the ear.</p><p>- You may also experience effects in other areas of your body including:</p><p><em><strong>Uncommon:</strong></em> headache, skin inflammation, fever</p><p>When used in the ear, the ingredients rarely cause redness, rash and itching. However, when applied to the skin, CIPROCIN may cause: rash, skin disease, peeling skin, serious inflammatory disease and skin eruptions, including wheals</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <ul><li>Keep out of the reach and sight of children.</li><li>Store below 30&deg;C. Protect from light.</li><li>Keep the bottle tightly closed.</li><li>Do not use the drops after the expiry date (marked &#39;Exp&#39;) on the bottle and the carton. The expiry date refers to the last day of that month.</li><li><strong>Stop using the bottle 1 month after first opening, </strong>to prevent infections.</li><li>Medicines should not be disposed off via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is ciprofloxacin Hydrochloride</p><p><strong>Sterile Eye /Ear Drops:</strong></p><ul><li>Each ml contains Ciprofloxacin Hydrochloride (USP) equivalent to Ciprofloxacin 3 mg, Benzalkonium Chloride Solution (BP) 0.2 mg (preservative).</li><li>The other ingredients are Sodium Chloride, Disodium Edetate and Water for injection</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                CIPROCIN Eye/Ear Drops is clear colourless to pale yellow solution free from particles.
Pack:
5 ml plastic bottle with white plastic cap and white pilfer proof.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Medical and Cosmetic Products Company Ltd. (Riyadh Pharma)</p><p>P.O.Box 442, Riyadh 11411</p><p>Fax: +966 11 265 0505</p><p>Email: contact@riyadhpharma.com</p><p>For any information about this medicinal product, please contact the local representative of marketing authorisation holder:</p><p>Saudi Arabia Marketing department</p><p>Riyadh</p><p>Tel: +966 11 265 0111</p><p>Email:marketing@riyadhpharma.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was revised in (09/2020)
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>سيبروسـيـن</strong> ينتمـــي إلـــى مجموعة مـــن الأدويـــة المعروفة باســـم المضادات الحيويـــة الكينولـــون. يســـتخدم لعـــلاج قرحة القرنيـــة وبعـــض الالتهابات البكتيريـــة الاخـــرى للعين.</p><p dir="RTL"><strong>سيبروسـين </strong>يحتـــوي علـــى سيبروفلوكساســـن ، وهـــو مضاد حيـــوي فعال ضـــد العديد من أنـــواع الجراثيم التي تســـبب العـــدوى البكتيرية في أذنك )أذنيك). يســـتخدم لعـــاج الالتهابات الحـادة في الاذن الخارجية (التهاب الاذن الخارجية أو &quot;أذن الســـباح&quot;)</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستخدم سيبروسين...</strong></p><ul dir="rtl"><li>إذا كان لديـــك حساســـية (الحساسية) لسيبروفلوكساســيـن أو أي مـــن المضـــادات الحيويـــة الكينولونية الاخـــرى أو إلى أي مـــن المكونات الأخـــرى المدرجـــة في القســـم 6 . إســـأل طبيبـــك للحصول على المشـــورة</li><li>فقط اســـتخدم سيبروسين في الاطفال الذين تقل أعمارهم عن سنة واحدة إذا تم وصفه بواســـطة طبيبك.</li></ul><p dir="RTL"><strong>عناية خاصة...</strong></p><ul dir="rtl"><li>استخدم فقط سيبروسين في عينيك أو أذنيك.</li><li>كمـــا هـــو الحال مع أي مضاد حيوي، قد يؤدي اســـتخدام سيبروســيـن ً لفتـــرة طويلـــة إلى عـــدوى أخرى. إذا كانـــت الاعراض تزداد ســـوءا أو عـــادت فجأة، أخبر طبيبـــك. قد تصبح أكثر عرضـــة للإصابة بعدوى أخرى مع اســـتخدام هذا الـــدواء، خاصة بعد الاســـتخدام المطول.</li><li>إذا لاحظـــت العلامات الاولى لطفـــح جلدي أو أي رد فعل تحسســـي آخـــر، مبـــا في ذلك الارتكاريـــا والحكة، مشـــاكل التنفـــس ، توقف عن العــلاج واتصـــل بطبيبك علـــى الفور. إذا كان لديك رد فعل تحسســـي خطيـــر فقـــد تحتاج إلى عـــلاج طارئ.</li><li>&nbsp;إذا شـــعرت بألـــم أو تـــورم أو التهـــاب أثنـــاء أو بعـــد فتـــرة قصيرة من تنـــاول هذا الـــدواء، توقـــف عن العـــلاج واتصـــل بطبيبك. ً</li><li>&nbsp;إذا كنت مســـنا أو إذا كنت تتناول أدوية تســـمى &quot;الكورتيكوستيرويدات&quot; تســـتخدم لعـــلاج حـــالات مثل الالـــم والالتهابـــات أو الربو أو مشـــاكل الجلــد، فأنت معرض بشـــكل أكبر لخطر الاصابة بمشـــاكل في الاوتار أثنـــاء العـــلاج بـ سيبروســـن. إذا واجهت أي التهـــاب أو حالة التهابية، توقـــف عن العلاج واستشـــر طبيبـــك على الفور.</li><li>تجنب أشعة الشمس الزائدة أثناء استخدام سيبروسين.</li></ul><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">إذا كنتـــي حامـــلا أو قـــد تكونـــي حامـــلا، أو إذا كنتـــي تقومـــن بالرضاعة الطبيعيـــة للطفـــل، تحدثـــي مـــع طبيبك قبل اســـتخدام سيبروســيـن.</p><p dir="RTL">&nbsp;<strong>القيادة واستخدام الالات</strong></p><p>قـــد تكـــون الرؤيـــة غير واضحـــة مؤقتا أو تأثرت بأي شـــكل من الاشـــكال بعـــد اســـتخدام سيبروسـيــن يجـــب ألا تقـــود أو تشـــغل الالات حتى تصبح رؤيتـــك واضحة مـــرة أخرى</p><p dir="RTL"><strong>استخدام أدوية أخرى</strong></p><p dir="RTL"><strong>أخبــر طبيبــك أو الصيدلــي</strong> إذا كنـــت تســـتخدم أو اســـتخدمت مؤخرا أي أدويـــة أخـــرى، بـمــا في ذلـــك الادوية التـــي تم الحصول عليهـــا دون وصفة طبيـــة. إذا كنـــت تســـتخدم أكثـــر مـــن نـــوع واحد مـــن دواء العيـــون، يجب اســـتخدام الادويـــة على الأقـــل بــ 5 دقائـــق بينهما.</p><p dir="RTL">يجب استخدام مراهم العين بعد كل العلاجات.</p><p dir="RTL"><strong>معلومات هامة</strong> <strong>إذا كنت ترتدي العدسات اللاصقة</strong></p><p dir="RTL">هنـــاك مـــادة حافظـــة في سيبروســيـن (كلوريـــد البنزالكونيـــوم) التـــي قـــد تســـبب تهيـــج العــيـن وممكـــن أن تغيـــر لـــون العدســـات اللاصقـــة اللينة.</p><p dir="RTL">لا ترتـــدي العدســـات اللاصقـــة (الصلبـــة أو الناعمة) خلال فتـــرة العلاج مـــع سيبروســيـن. إذا اســـتمريت في ارتداء العدســـات الخاصـــة بك، يجب إزالتهـــا قبـــل اســـتخدام سيبروســيـن وانتظـــر 15 دقيقـــة علـــى الأقل بعد اســـتخدام وقبـــل وضـــع العدســـات الخاصة بك مـــرة أخرى.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">دائمـــا اســـتخدم سيبروســـن تمامـــا كمـــا قـــال لـــك طبيبك. يجـــب عليك مراجعـــة الطبيـــب أو الصيدلـــي إذا لـــم تكـــن متأكدا.</p><p dir="RTL"><strong>قرحة القرنية</strong></p><p dir="RTL">تستمر الجرعات خلال الليل.</p><p dir="RTL">اليـــوم األول - 2 قطـــرة كل 15 دقيقـــة أول 6 ســـاعات ثـــم 2 قطـــرة كل 30 &nbsp;دقيقـــة.</p><p dir="RTL">اليوم الثاني - 2 قطرة كل ساعة.</p><p dir="RTL">اليوم الثالث إلى اليوم 14 - 2 قطرة كل 4 ساعات.</p><p dir="RTL">ســـيخبرك طبيبـــك إذا كان العـــلاج بحاجة إلى الاســـتمرار لمــدة تزيد عن 14 &nbsp;يوما.</p><p dir="RTL"><strong>الالتهابات البكتيرية الاخرى</strong></p><p dir="RTL">1 أو 2 قطـــرة 4 مـــرات في اليـــوم. بالنســـبة للعـــدوى الشـــديدة ، يمكـــن زيـــادة الجرعـــة في أول يومـــين إلـــى 1-2 قطـــرة كل ســـاعتين ، بينما تكون مستيقظا .</p><p dir="RTL">مـــن المهم أن تســـتمر في اســـتخدام سيبروسـيــن لفتـــرة العــلاج كاملة كما نصـــح طبيبـــك حتى لو تحســـنت الاعراض. إذا توقفت عن اســـتخدام هذا &nbsp;الـــدواء في وقـــت مبكـــر جدا، فقد تحـــدث الاعراض مـــرة أخرى. &nbsp;</p><p dir="RTL">يجـــب ألا تســـتخدم سيبروســيـن أكثـــر مـــن 21 يومـــا ، مـــا لـــم يخبـــرك طبيبـــك غيـــر ذلك.</p><p dir="RTL">قم بإزالة طوق الامان من الغطاء عندما يتم فتح الزجاجة لأول مرة.</p><p dir="RTL">دائمـــا اســـتخدام سيبروسـيــن تمامـــا كمـــا أخبـــر طبيبـــك. يجـــب عليـــك استشـــارة طبيبـــك أو الصيدلـــي إذا كنـــت غيـــر متأكـــد.</p><p dir="RTL"><strong>الاستخدام في الأذن</strong><strong>: </strong></p><p dir="RTL">الجرعة المعتادة</p><p dir="RTL">&nbsp;البالغون: 4 قطرات في قناة الأذن ، مرتين يوميا - صباحا ومساءا.</p><p dir="RTL">ألاطفـــال (أكثـــر من عـــام واحد): 3 قطـــرات في قنـــاة الأذن ، مرتنين يوميا - صباحا ومساءا.</p><p dir="RTL">قم بإزالة طوق الأمان من الغطاء عندما يتم فتح الزجاجة لأول مرة.</p><p dir="RTL">ســـيخبرك طبيبـــك إلـــى متى سيســـتمر علاجك مـــع سيبروسـيــن. للتأكد مـــن أن العـــدوى لا تعـــود ، لا تتوقـــف عـــن العـــلاج في وقـــت مبكـــر، حتى لو شـــعرت أذنيك بتحســـن.</p><p dir="RTL">كمـــا هـــو الحـال مـــع أي مضاد حيـــوي، قد يؤدي اســـتخدام سيبروســيـن لفتـــرة أطـــول ممـــا ينصح بـــه إلى إصابـــات أخرى. استخدم فقط سيبروسين في كلتا الأذنين إذا أخبرك طبيبك بذلك.</p><p dir="RTL">دائمـــا اســـتخدام سيبروســيـن تمامـــا كمـــا أخبـــر طبيبـــك.</p><p dir="RTL">يجـــب عليـــك استشـــارة طبيبـــك أو الصيدلـــي إذا كنـــت غيـــر متأكـــد.</p><p dir="RTL"><strong>تعليمات عامة</strong></p><ul dir="rtl"><li>اغسل يديك قبل أن تبدأ.</li><li>لف غطاء العبوة.</li><li>&nbsp;أمسك الزجاجة مشيرا إلى أسفل، بين الابهام والأصابع</li></ul><p dir="RTL"><strong>الاستخدام في العين:&nbsp; </strong></p><ul dir="rtl"><li>أدر رأسك إلى الوراء.</li><li>اســـحب أســـفل الجفن السفلي باســـتخدام إصبع، حتـــى يكون هنـــاك &quot;جيب&quot; بين الجفـــن والعين. فإن القطرة ســـيتم وضعها في هـــذا المكان.</li><li>ضع طرف العبوة على مقربة من العين.</li><li>افعل ذلك أمام المرآة إذا كان ذلك أفضل</li><li>لا تلمـــس عينيـــك أو الجفـــن، والمناطـــق المحيطـــة بهـــا أو الاســـطح الأخـــرى بالقطـــارة. مـــن الممكن أن تتلـــوث القطـــارة. اضغـــط برفـــق علـــى قاعدة العبـــوة لوضـــع قطرة واحـــدة في كل مـــرة.</li><li>لا تعصر العبوة، فقط اضغط برفق بأسفل القطارة.</li><li>إذا كنـــت تســـتخدم القطـــرة في كلتـــا العينـــن، كـــرر الخطـــوات للعين الاخرى أعـــد غطـــاء العبـــوة جيـــدا بعد الاســـتعمال مباشـــرة.</li><li>&nbsp;إذا اخطأت في وضع القطرة داخل عينيك، حاول مرة أخرى.</li></ul><p dir="RTL"><strong>إذا نســيت اســتخدام سيبروســبن، </strong>لا تقلـــق، فقـــط اســـتخدمه عنـــد الموعد المقبـــل. <strong>لا تســتخدم جرعــة مضاعفــة للتعويــض</strong><strong>. </strong></p><p dir="RTL"><strong>إذا اســتخدمت سيبروسيــن أكثــر ممــا يجــب</strong> يمكـــن غســـلها مـــن عينيـــك بالمـــاء الفاتر.</p><p dir="RTL"><strong>إذا ابتلعــت هــذا الــدواء عن طريق الخطأ</strong>، فمن غير المحتمل أن يســـبب أي مشـــاكل خطيرة، ولكن اتصل بطبيبك.</p><p dir="RTL"><strong>الاستخدام في الأذن</strong><strong>: </strong></p><ul dir="rtl"><li>اســـتلق علـــى جانبـــك بحيـــث تكـــون الأذن المصابـــة متجهـــة للأعلى.</li><li>قم بوضع طرف العبوة بالقرب من قناة الأذن.</li><li>لا تلمـــس الأصابـــع أو الأذن أو أي أســـطح أخـــرى بطـــرف الزجاجـــة لأنهـــا قـــد تصيـــب القطـــرات بالعـــدوى.</li><li>اضغـــط بلطـــف علـــى قاعـــدة العبـــوة لوضـــع قطرة واحـــدة مـــن سيبروسـيــن في كل مـــرة.</li><li>لا تضغـــط علـــى الزجاجـــة. الضغـــط اللطيف على القاع هـــو كل مـــا تحتاجه.</li><li>ابـــق علـــى جانبـــك - يجـــب أن يبقى المريـــض على جانبه لمـــدة خمس دقائـــق على الأقل للمســـاعدة في عمـــل القطـــرات داخل الأذن.</li><li>اذا كانت كلتا أذنيك مصابة، فكرر الخطوات بالأذن الأخرى.</li><li>ضع غطاء العبوة مرة أخرى وأحكم الاغلاق.</li></ul><p dir="RTL"><strong>إذا كان لديــك أي اســئلة أخـــرى حـــول اســـتخدام سيبروســيـن ،</strong> إســـأل طبيبـــك أو الصيدلـــي</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثـــل جميـــع الادويـــة، يمكن أن تتســـبب سيبروسـيــن في آثـــار جانبية، وإن كان ذلـــك لا يحـــدث للجميع.</p><p dir="RTL"><strong>قد تعاني من بعض أو كل التأثيرات التالية في عينك (عينيك): </strong></p><p dir="RTL"><strong><em>شــائعة</em></strong> (1 إلى 10 مســـتخدمين في كل 100) رواســـب بيضاء على ســـطح العـــن (القرنيـــة)، شـــعور بعـــدم الراحـــة (لســـع أو حـــرق، شـــعور حاد في العــيـن، تهيـــج)، احمرار.</p><p dir="RTL"><strong><em>غيــر شــائعة</em></strong> (1 إلـــى 10 مســـتخدمين في كل 1000) أضـــرار على ســـطح العـــن (القرنيـــة)، والحساســـية للضـــوء، عدم وضـــوح الرؤية، تـــورم العين أو الجفـــن، الألـــم، جفـــاف العين، الحكـــة، إفرازات العين، تقشـــير الجفن، قشـــور الجفـــن، احمـــرار الجفـــن، وضعـــف الرؤيـــة، عيـــون مائيـــة، عيون حمراء.</p><p dir="RTL"><strong><em>نــادرة</em></strong> (1 إلـــى 10 مســـتخدمني في كل 10000) تلـــف في العـيــن، التهـــاب، رؤيـــة مزدوجـــة، انخفـــاض الاحســـاس بالعــيـن، عيون متعبـــة، صبغة.</p><p dir="RTL"><strong>إذا لاحظــت وجــود جزيئــات بيضــاء في عينيــك،</strong> اســـتمر في اســـتخدام سيبروسـيــن ولكـــن أخبـــر طبيبـــك علـــى الفـــور.</p><p dir="RTL">- قد تواجه أيضا تأثيرات في مناطق أخرى من جسمك بما في ذلك:</p><p dir="RTL"><strong><em>شائعة:</em></strong> الطعم السيئ.</p><p dir="RTL"><strong><em>غير شائعة:</em></strong> صداع، غثيان.</p><p dir="RTL"><strong><em>نــادرة:</em></strong> فـــرط الحساســـية، الدوخـــة، ألـــم الاذن، التهـــاب داخـــل األأنـــف، إفـــرازات الجيـــوب الأنفيـــة، إســـهال، ألـــم بطنـــي، التهاب الجلـــد، مرض في الأوتـــار. &nbsp;</p><p dir="RTL"><strong>قد تواجه بعض أو كل التأثيرات التالية في أذنك (أذنيك</strong><strong>(</strong><strong>:</strong></p><p dir="RTL"><strong><em>غيــر شــائعة</em></strong> (تؤثـــر في 1 إلـــى 10 أشـــخاص من كل 1000): ألـــم، احتقان، أذن دامعـــة، حكـــة، رنين في األذن.</p><p dir="RTL">- قد تواجه أيضا تأثيرات في مناطق أخرى من جسمك بما في ذلك:</p><p dir="RTL"><strong><em>غير شائعة:</em></strong> صداع، التهاب الجلد، حمى.</p><p dir="RTL">عند استخدامها في الاذن نادرا مـــا تتســـبب المكونات في الاحمرار والطفـــح الجلـــدي والحكة. ومـــع ذلك، عند اســـتخدامها علـــى الجلد، قد تســـبب قطـــرة سيبروســيـن: طفح جلـــدي، مرض جلـــدي، تقشـــير الجلد، مـــرض التهابـــي خطير وطفـــح جلـــدي، وبثور.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul dir="rtl"><li>يحفظ بعيدا عن متناول أيدي ونظر الأطفال.</li><li>يحفظ يف درجة حرارة أقل من 30 درجة مئوية بعيدا عن الضوء.</li><li>حافظ على الزجاجة مغلقة بإحكام.</li><li>لا تســـتخدم القطرات بعد تاريخ الانتهـــاء (EXP) المدون على العبوة والكرتـــون. تاريخ الانتهاء يشـــير إلى اليوم الأخير من ذلك الشـــهر.</li><li><strong>توقــف عــن اســتخدام العبــوة بعــد شــهر واحــد مــن أول فتــح لهــا</strong>، لمنع العدوى.</li><li>لا ينبغـــي التخلـــص مـــن الأدوية عن طريـــق مياه الصـــرف الصحي أو النفايـــات المنزليـــة. اســـأل الصيدلي عـــن كيفية التخلص مـــن الأدوية التـــي لم تعد مطلوبة. ســـوف تســـاعد هـــذه التدابير لحمايـــة البيئة.</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي سيبروفلوكساسين هيدروكلورايد</p><p dir="RTL"><strong>&nbsp;قطرة للعين/ للأذن</strong><strong>:</strong></p><p dir="RTL">يحتـــوي كل 1 مل على سيبروفلوكساسـيــن هيدروكلورايد (دســـتور الأدوية الأمريكـــي) مـــا يعـــادل سيبروفلوكساسـيــن 3 ملجـــم ، محلـــول كلوريـــد البينزالكونيـــوم (دســـتور الأدويـــة البريطانـــي) 2.0 ملجم (مـــادة حافظة)</p><p dir="RTL">المكونـــات الأخـــرى هـــي صوديـــوم كلورايـــد، داي صوديـــوم ايديتيت و مـــاء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">سيبروســيـن نقـــط للعين والأذن عبـــارة عن محلول صافي عـــديم اللون الى أصفـــر باهت خالي مـــن الجزيئات.</p><p dir="RTL"><strong>العبوة</strong><strong>: </strong></p><p dir="RTL">&nbsp;5 مـــل عبـــوة بلاســـتيكية مع غطـــاء من البلاســـتيك الأبيض وأمـــان الفتح الأبيض</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">شركة المنتجات الطبية والتجميلية احملدودة (الرياض فارما)</p><p dir="RTL">&nbsp;ص.ب. 442 الرياض 11411</p><p dir="RTL">فاكس: 966112650505+</p><p dir="RTL">&nbsp;البريد الالكتروني: contact@riyadhpharma.com</p><p dir="RTL">أيـــة معلومـــات عـــن هذا المنتـــج الطبـــي، يرجـــى الاتصال علـــى صاحب الترخيص والتســـويق:</p><p dir="RTL">المملكة العربية السعودية</p><p dir="RTL">قسم التسويق</p><p dir="RTL">الرياض</p><p dir="RTL">تلفون: &nbsp;966112650111+</p><p dir="RTL">البريد الالكتروني: marketing@riyadhpharma.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشره بتاريخ (09/2009)  رقم النسخه (01)
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ciprocin Sterile Eye/Ear drops 0.3%
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each ml contains Ciprofloxacin hydrochloride equivalent to Ciprofloxacin 3 mg, Benzalkonium Chloride Solution (BP) 0.2 mg (preservative).
For excipients, see 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Eye/Ear drops solution
Clear, colorless to pale yellow solution free from particles.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>EYE:</strong></p><p>Adults, newborn infants (0-27 days), infants and toddlers (28 days to 23 months), children (2-11 years) and adolescents (12 &ndash; 16 years)</p><p>CIPROCIN is indicated for the treatment of corneal ulcers and superficial infections of the eye and adnexa caused by susceptible strains of bacteria.</p><p>Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p><p>&nbsp;</p><p><strong>EAR:</strong></p><p><u>Adults and Children 1 year and above</u></p><p>CIPROCIN is indicated for acute otitis externa due to susceptible strains of bacterial species shown to be responsive to ciprofloxacin as listed in section 5.1.</p><p>Use should be under the supervision of a specialist ENT service having the facilities for regular monitoring of clinical and microbiological effects during and after administration.</p><p>Consideration should be given to official guidance on the appropriate use of antibacterial agents.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>EYE:</strong></p><p>Adults, newborn infants (0-27 days), infants and toddlers (28 days to 23 months), children (2-11 years) and adolescents (12 &ndash; 16 years)</p><p><u>Corneal Ulcers:</u></p><p>CIPROCIN must be administered in the following intervals, even during night time:</p><p>On the first day, instil 2 drops into the affected eye every 15 minutes for the first six hours and then 2 drops into the affected eye every 30 minutes for the remainder of the day.</p><p>On the second day, instil 2 drops in the affected eye hourly.</p><p>On the third through the fourteenth day, place two drops in the affected eye every 4 hours. If the patient needs to be treated longer than 14 days, the dosing regimen is at the discretion of the attending physician.</p><p><u>Superficial Ocular Infection:</u></p><p>The usual dose is one or two drops in the affected eye(s) four times a day. In severe infections, the dosage for the first two days may be one or two drops every two hours during waking hours.</p><p>For either indication a maximum duration of therapy of 21 days is recommended.</p><p>The dosage in children above the age of 1 year is the same as for adults.</p><p><u>Use in children</u></p><p>Safety and effectiveness of CIPROCIN Eye Drops were determined in 230 children between the ages of 0 and 12 years of age. No serious adverse drug reaction was reported in this group of patients.</p><p>&nbsp;</p><p><u>Use in renal and hepatic impairment</u></p><p>No studies have been performed using CIPROCIN Eye Drops in patients with kidney or liver problems.</p><p>&nbsp;</p><p><strong>EAR:</strong></p><p><u>Adults and children 1 year and above:</u></p><p>The dose is 4 drops of CIPROCIN in the ear canal twice daily for adults.</p><p>For patients requiring use of an otowick, the dose can be doubled for the first administration only (i.e., 6 drops for paediatric patients and 8 drops for adult patients).</p><p><u>Use in elderly</u></p><p>No dosage alteration in elderly patients is necessary.</p><p>In clinical studies conducted with CIPROCIN, the probability of having an adverse reaction was independent of age. No difference in patients experiencing adverse reactions was noted in patients less than 65 years of age, between 65 and 75 years of age, and greater than 75 years of age.</p><p><u>Use in children</u></p><p>The dose is 3 drops of CIPROCIN in the ear canal twice daily for children. Safety and effectiveness of CIPROCIN was determined in 139 children between the ages of one and 12 years. No serious adverse events were reported in these patients.</p><p>Safety and effectiveness in children below 1 year of age have not been established.</p><p><u>Use in hepatic and renal impairment</u></p><p>CIPROCIN has not been studied in patients with hepatic or renal impairment and is therefore not recommended in such patients.</p><p><u>Method of administration</u></p><p>The bottle should be shaken well before use.</p><p><u>After cap is removed, if tamper evident snap collar is loose, remove before using product.</u></p><p>The user should be instructed to warm the bottle just before use by holding it in the palm of the hand for a few minutes to prevent any unpleasant sensation associated with the cold suspension coming into contact with the ear.</p><p>With head tilted, instil the drops into the affected ear. Keep the head tilted on its side for around 5 minutes to enable the drops to penetrate into the external auditory canal. Repeat if necessary in the other ear.</p><p>To prevent contamination of the dropper tip and solution, care must be taken not to touch the auricle or the external ear canal, and surrounding areas, or other surfaces with the dropper tip of the bottle. Keep the bottle tightly closed when not in use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                • Hypersensitivity to the active substance or to any of the excipients listed in Section 6.1.
• Hypersensitivity to quinolones
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After cap is removed, if tamper evident snap collar is loose, remove before using product.</p><p><strong>For Ocular use only:</strong></p><p>The clinical experience in children less than one year old, particularly in neonates is very limited. The use of CIPROCIN eye drops in neonates with ophthalmia neonatorum of gonococcal or chalamydial origin is not recommended as it has not been evaluated in such patients. Neonates with ophthalmia neonatorum should receive appropriate treatment for their condition.</p><p>When using CIPROCIN eye drops one should take into account the risk of rhinopharyngeal passage which can contribute to the occurrence and the diffusion of bacterial resistance</p><p>Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, were observed in patients receiving treatment based on systematically administered quinolones. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, tingling, pharyngeal or facial oedema, dyspnoea, urticaria and itching. Only a few patients had a history of hypersensitivity reactions. (See section 4.8)</p><p>Serious acute hypersensitivity reactions to ciprofloxacin may require immediate emergency treatment. Oxygen and airway management should be administered where clinically indicated.</p><p>CIPROCIN should be discontinued at the first appearance of skin rash or any other sign of hypersensitivity.</p><p>As with all antibacterial preparations prolonged use may lead to overgrowth of non-susceptible bacterial strains or fungi. If superinfection occurs, appropriate therapy should be initiated.</p><p>Tendon inflammation and rupture may occur with systemic fluoroquinolone therapy including ciprofloxacin, particularly in elderly patients and those treated concurrently with corticosteroids. Therefore, treatment with CIPROCIN Eye Drops should be discontinued at the first sign of tendon inflammation (See section 4.8).</p><p>In patients with corneal ulcer and frequent administration of CIPROCIN Eye Drops, white topical ocular precipitates (medication residue) have been observed which resolved after continued application of CIPROCIN Eye Drops. The precipitate does not preclude the continued application of CIPROCIN Eye Drops nor does it adversely affect the clinical course of the recovery process. The onset of the precipitate was within 24 hours to 7 days after starting therapy. Resolution of the precipitate varied from immediately to 13 days after therapy commencing.</p><p>Contact lens wear is not recommended during treatment of an ocular infection. Therefore, patients should be advised not to wear contact lenses during treatment with CIPROCIN eye drops.</p><p>CIPROCIN Eye Drops contains benzalkonium chloride which may cause irritation and is known to discolour soft contact lenses.</p><p>Avoid contact with soft contact lenses. In case patients are allowed to wear contact lenses they should be instructed to remove them prior to application of CIPROCIN Eye Drops and wait at least 15 minutes before reinsertion.</p><p>&nbsp;</p><p><strong>For Otic use only:</strong></p><p>&bull; The safety and efficacy of this product have been established in paediatric patients 1 year and older in controlled clinical trials. Although very limited data are available in patients less than age 1 year treated for acute otitis externa, there are no differences in the disease process itself, in this patient population, which would preclude use of this product in patients less than one year of age. Based upon the very limited data, the prescribing physician should weigh the clinical benefits of use against the known and possibly unknown risks when prescribing in patients less than age 1 year.</p><p>&bull; In otic use, meticulous medical monitoring is required in order to be able to determine in a timely manner the possible necessity of other therapeutic measures.</p><p>&bull; Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolone therapy. Some reactions were accompanied by cardiovascular collapse, loss of consciousness tingling, pharyngeal or facial oedema, dyspnoea, urticaria and itching. Only a few patients had a history of hypersensitivity reactions. (See section 4.8)</p><p>&bull; Serious anaphylactic reactions require immediate emergency treatment with epinephrine and other resuscitation measures, including oxygen, intravenous fluids, intravenous antihistamines, corticosteroids, pressor amines, and airway management, as clinically indicated.</p><p>&bull; CIPROCIN should be suspended immediately at the first appearance of a skin rash or any other sign of hypersensitivity reaction and medical advice should be sought.</p><p>&bull; Moderate to severe phototoxicity manifested as an exaggerated sunburn reaction has been observed in patients who are exposed to direct sunlight while receiving some members of the quinolone class of drugs. Excessive sunlight should be avoided. Therapy should be discontinued if phototoxicity occurs.</p><p>&bull; As with all antibacterial preparations prolonged use of Ciprofloxacin may result in overgrowth of non-susceptible organisms, including fungi. If super infection occurs, appropriate therapy should be initiated.</p><p>&bull; Tendon inflammation and rupture may occur with systemic fluoroquinolone therapy including ciprofloxacin, particularly in elderly patients and in those treated concurrently with corticosteroids. Therefore treatment with CIPROCIN should be discontinued at the first sign of tendon inflammation (see section 4.8).</p><p>&bull; Benzalkonium chloride, used as a preservative in this medicine is an irritant, may cause skin reactions when used topically.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Specific drug interaction studies have not been conducted with ophthalmic ciprofloxacin. Given the low systemic concentration of ciprofloxacin following topical ocular administration of the product, drug interactions are unlikely to occur.</p><p>If more than one topical ophthalmic medicinal product is being used, the medicines must be administered at least 5 minutes apart. Eye ointments should be administered last.</p><p>&nbsp;</p><p>Specific drug interaction studies have not been conducted with otic ciprofloxacin.</p><p>However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, enhance the effects of the oral anticoagulant, warfarin, and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.</p><p>Given the low systemic concentration of ciprofloxacin following otic administration of the product, drug interactions are unlikely to occur.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p>There are no adequate data from the use of CIPROCIN in pregnant woman. Animal studies do not indicate direct harmful effects with respect to reproductive toxicity. Systemic exposure to ciprofloxacin after topical use is expected to be low.</p><p>As a precautionary measure, it is preferable to avoid the use of CIPROCIN during pregnancy, unless the therapeutic benefit is expected to outweigh the potential risk to the fetus.</p><p>&nbsp;</p><p><strong>Breastfeeding</strong></p><p>Orally administered ciprofloxacin is excreted in the human milk. It is unknown whether ciprofloxacin is excreted in human breast milk following topical ocular or otic administration. A risk to the suckling child cannot be excluded. Therefore, caution should be exercised when CIPROCIN is administered to nursing women.</p><p>&nbsp;</p><p><strong>Fertility</strong></p><p>Studies have not been performed in humans to evaluate the effect of topical administration of ciprofloxacin on fertility. Oral administration in animals does not indicate direct harmful effects with respect to fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This product has no or negligible influence on the ability to drive or use machines.</p><p>Temporarily blurred vision or other visual disturbances may affect the ability to drive or use machines. If transient blurred vision occurs upon instillation, the patient must wait until the vision clears before driving or using machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Eye :</strong></p><p>In clinical trials, the most frequently reported adverse drug reactions were ocular discomfort, dysgeusia and corneal deposits occurring approximately in 6%, 3% and 3% of patients respectively.</p><p><u>Tabulated summary of adverse reactions</u></p><p>The adverse reactions listed below are classified according to the following convention: very common (&ge; 1/10), common (&ge; 1/100 to &lt;1/10), uncommon (&ge;1/1,000 to &lt;1/100), rare (&ge;1/10,000 to &lt;1/1,000), very rare (&lt;1/10,000), or not known (cannot be estimated from the available data). Within each frequency-grouping, adverse reactions are presented in order of decreasing seriousness. The adverse reactions have been observed during clinical trials and post-marketing experience.</p><p>The following undesirable effects were reported in association with the ophthalmic use of CIPROCIN:</p><table border="1" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Classification</strong></p></td><td style="vertical-align:top"><p><strong>MedDRA Preferred Term (v. 15.1)</strong></p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p><em>Rare:&nbsp;</em>hypersensitivity</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p><em>Uncommon:&nbsp;</em>headache</p><p><em>Rare:&nbsp;</em>dizziness</p></td></tr><tr><td style="vertical-align:top"><p>Eye disorders</p></td><td style="vertical-align:top"><p><em>Common</em>: corneal deposits, ocular discomfort, ocular hyperaemia</p><p><em>Uncommon</em>: keratopathy, punctate keratitis, corneal infiltrates, photophobia, visual acuity reduced, eyelid oedema, blurred vision, eye pain, dry eye, eye swelling, eye pruritus, lacrimation increased, eye discharge, eyelid margin crusting, eyelid exfoliation, conjunctival oedema, erythema of eyelid</p><p><em>Rare:&nbsp;</em>ocular toxicity, keratitis, conjunctivitis, corneal epithelium defect, diplopia, hypoaesthesia eye, asthenopia, eye irritation, eye inflammation, hordeolum</p></td></tr><tr><td style="vertical-align:top"><p>Ear and labyrinth disorders</p></td><td style="vertical-align:top"><p><em>Rare:&nbsp;</em>ear pain</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p><em>Rare:&nbsp;</em>paranasal sinus hypersecretion, rhinitis</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p><em>Common:&nbsp;</em>dysgeusia</p><p><em>Uncommon</em>: nausea</p><p><em>Rare:&nbsp;</em>diarrhoea, abdominal pain</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p><em>Rare</em>: dermatitis</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p><em>Not known:&nbsp;</em>tendon disorder</p></td></tr></tbody></table><p><u>Description of selected adverse events</u></p><p>With locally applied fluoroquinolones (generalized) rash, toxic epidermolysis, dermatitis exfoliative, Stevens-Johnson syndrome and urticaria occur very rarely.</p><p>Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolone therapy (see section 4.4). Some reactions were accompanied by cardiovascular collapse, loss of consciousness, tingling, pharyngeal or facial oedema, dyspnoea, urticaria, and itching.</p><p>Ruptures of the shoulder, hand, Achilles, or other tendons that required surgical repair or resulted in prolonged disability have been reported in patients receiving systemic fluoroquinolones. Studies and post marketing experience with systemic fluoroquinolones indicate that the risk of these ruptures may be increased in patients receiving corticosteroids, especially geriatric patients and in tendons under high stress, including the Achilles tendon. To date, clinical and post marketing data have not demonstrated a clear association between CIPROCIN and musculoskeletal and connective tissue adverse reactions.</p><p>In isolated cases blurred vision, decreased visual acuity and medication residue have been observed with ophthalmic ciprofloxacin (see section 4.4).</p><p>Moderate to severe phototoxicity has been observed in patients treated with systemic quinolones. Nevertheless, phototoxic reactions to ciprofloxacin are uncommon.</p><p><u>Paediatric population</u></p><p>Safety and effectiveness of CIPROCIN 3mg/ml eye drops were determined in 230 children between the ages of 0 and 12 years of age. No serious adverse drug reaction was reported in this group of patients.</p><p>&nbsp;</p><p><strong>Ear:</strong></p><p>In clinical trials the most frequently reported adverse drug reactions were ear pruritus and otorrhoea occurring approximately in1% of patients.</p><p>The adverse reactions listed below are classified according to the following convention: very common (&ge; 1/10), common (&ge; 1/100 to &lt;1/10), uncommon (&ge;1/1,000 to &lt;1/100), rare (&ge;1/10,000 to &lt;1/1,000), very rare (&lt;1/10,000), or not known (cannot be estimated from the available data). Within each frequency-grouping, adverse reactions are presented in order of decreasing seriousness. The adverse reactions have been observed during clinical trials and post-marketing experience.</p><table border="1" cellspacing="0" cellpadding="0" style="width:95%"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Classification</strong></p></td><td style="vertical-align:top"><p><strong>MedDRA Preferred Term (v. 15.0)</strong></p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p><em>Uncommon</em>: headache</p></td></tr><tr><td style="vertical-align:top"><p>Ear and labyrinth disorders</p></td><td style="vertical-align:top"><p><em>Uncommon</em>: ear pain, ear congestion, otorrhoea, ear pruritus, tinnitus</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p><em>Uncommon</em>: dermatitis</p></td></tr><tr><td style="vertical-align:top"><p>General disorders and administration site conditions</p></td><td style="vertical-align:top"><p><em>Uncommon:</em>&nbsp;pyrexia</p></td></tr></tbody></table><p><u>Description of selected adverse events</u></p><p>In otic use the ingredients rarely are sensitising. However as with any substance that is applied to the skin, an allergic reaction to any of the ingredients of the preparation can always occur.</p><p>Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolone therapy. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, tingling, pharyngeal or facial oedema, dyspnoea, urticaria, and itching.</p><p>Ruptures of the shoulder, hand, Achilles, or other tendons that required surgical repair or resulted in prolonged disability have been reported in patients receiving systemic fluoroquinolones. Studies and post marketing experience with systemic fluoroquinolones indicate that the risk of these ruptures may be increased in patients receiving corticosteroids, especially geriatric patients and in tendons under high stress, including the Achilles tendon. To date, clinical and post marketing data have not demonstrated a clear association between CIPROCIN and musculoskeletal and connective tissue adverse reactions.</p><p>With locally applied fluoroquinolones (generalized) rash, toxic epidermolysis, dermatitis exfoliative, Stevens-Johnson syndrome and urticaria occur very rarely.</p><p>Moderate to severe phototoxicity has been observed in patients treated with systemic quinolones. Nevertheless, phototoxic reactions to ciprofloxacin are uncommon.</p><p><u>Paediatric population</u></p><p>Safety and efficacy of CIPROCIN 3mg/ml ear drops was determined in 193 children between the ages of one and 12 years of age. No serious adverse drug reaction was reported in this group of patients.</p><p>&nbsp;</p><p>To report any side effects</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; National Pharmacovigilance and Drug Safety Center (NPC)</p><ul><li>Fax: +966-11-205-7662</li><li>Call NPC at +966-11-2038222, Ext 2317-2356-2340</li><li>Call Center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: https://ade.sfda.gov.sa</li></ul><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Eye :</strong></p><p>A topical overdose of CIPROCIN may be rinsed out from the eye(s) with lukewarm tap water. Due to the characteristics of this preparation no toxic effects are to be expected with an ocular overdose of this product, or in the event of accidental ingestion of the contents of one bottle.</p><p>&nbsp;</p><p><strong>Ear :</strong></p><p>No case of overdose has been reported. No data are available in humans regarding overdosage by accidental or deliberate ingestion. Due to the characteristics of this preparation no toxic effects are to be expected with an otic overdose of this product, or in the event of accidental ingestion of the contents of one bottle.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Eye :</strong></p><p>Pharmacotherapeutic Group &ndash; Ophthalmologicals, Other Anti-infectives</p><p>ATC Code: S01A X13</p><p><strong><u>Ear :</u></strong></p><p>Pharmacotherapeutic group: Otological; Anti-infectives.</p><p>ATC Code: S02A A.</p><p><u>Mechanism of Action</u></p><p>CIPROCIN eye/ear drops, solution contains the fluoroquinolone ciprofloxacin. The cidal and inhibitory activity of ciprofloxacin against bacteria results from an interference with the DNA gyrase, an enzyme needed by the bacterium for the synthesis of DNA. Thus the vital information from the bacterial chromosomes cannot be transcribed which causes a breakdown of the bacterial metabolism. Ciprofloxacin has&nbsp;<em>in vitro&nbsp;</em>activity against a wide range of Gram-positive and Gram-negative bacteria.</p><p><strong><u>Mechanism of Resistance</u></strong></p><p>Fluoroquinolone resistance, particularly ciprofloxacin, requires significant genetic changes in one or more of five major bacterial mechanisms: a) enzymes for DNA synthesis, b) protecting proteins, c) cell permeability, d) drug efflux, or e) plasmid-mediated aminoglycoside 6&rsquo;-N-acetyltransferase, AAC (6&rsquo;)-Ib.</p><p>Fluoroquinolones, including ciprofloxacin, differ in chemical structure and mode of action from aminoglycosides, &beta;-lactam antibiotics, macrolides, tetracyclines, sulfonamides, trimethoprim, and chloramphenicol. Therefore, organisms resistant to these drugs may be susceptible to ciprofloxacin.</p><p><u>Breakpoints:</u></p><p>There are no official topical ocular breakpoints for ciprofloxacin and although systemic breakpoints have been used, their relevance to topical therapy is doubtful. The EUCAST clinical MIC breakpoints used for this antibiotic are the following:</p><table border="0" cellspacing="0" cellpadding="0" style="width:691px"><tbody><tr><td style="vertical-align:top"><p><em>Staphylococcus</em>&nbsp;species</p></td><td style="vertical-align:top"><p>S &le; 1mg/l, R &ge; 1mg/l</p></td></tr><tr><td style="vertical-align:top"><p><em>Streptococcus pneumoniae</em></p></td><td style="vertical-align:top"><p>S &le; 0.125mg/l, R &ge; 2mg/l</p></td></tr><tr><td style="vertical-align:top"><p><em>Haemophilus influenzae</em></p></td><td style="vertical-align:top"><p>S &le; 0.5mg/l, R &ge; 0.5mg/l</p></td></tr><tr><td style="vertical-align:top"><p><em>Moraxella catarrhalis</em></p></td><td style="vertical-align:top"><p>S &le; 0.5mg/l, R &ge; 0.5mg/l</p></td></tr><tr><td style="vertical-align:top"><p><em>Pseudomonas aeruginosa</em></p></td><td style="vertical-align:top"><p>S &le; 0.5mg/l, R &ge; 1mg/l</p></td></tr></tbody></table><p><u>Susceptibility to Ciprofloxacin:</u></p><p>The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable. The presentation below lists bacterial species recovered from external ocular infections of the eye.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>Commonly susceptible species<strong> </strong></p><p><strong>Aerobic Gram-positive microorganisms</strong></p><p><em>Corynebacterium accolens</em></p><p><em>Corynebacterium auris</em></p><p><em>Corynebacterium propinquum</em></p><p><em>Corynebacterium psudodiphtheriticum</em></p><p><em>Corynebacterium striatum</em></p><p><em>Staphylococcus aureus</em>&nbsp;(methicillin susceptible &ndash; MSSA)</p><p><em>Staphylococcus capitis</em></p><p><em>Staphylococcus epidermidis</em>&nbsp;(methicillin susceptible &ndash; MSSE)</p><p><em>Staphylococcus hominis</em></p><p><em>Staphylococcus saprophyticus</em></p><p><em>Staphylococcus warneri</em></p><p><em>Streptococcus pneumoniae</em></p><p><em>Streptococcus viridans Group</em></p><p><strong>Aerobic Gram-negative microorganisms</strong></p><p><em>Acinetobacter species</em></p><p><em>Haemophilus nfluenza</em></p><p><em>Moraxella catarrhalis</em></p><p><em>Pseudomonas aeruginosa</em></p><p><em>Serratia marcescens</em></p><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><em>Species for which acquired resistance may be a problem</em></p><p><strong><em>Aerobic Gram-positive micro-organisms:</em></strong></p><p><em>Staphylococcus aureus&nbsp;(methicillin resistant &ndash; MRSA)</em></p><p><em>Staphylococcus epidermidis&nbsp;(methicillin resistant &ndash; MRSE)</em></p><p><em>Staphylococcus lugdunensis</em></p><p><strong><em>Aerobic Gram-negative micro-organisms:</em></strong></p><p><em>None</em></p><p><strong><em>Other micro-organisms:</em></strong></p><p><em>None</em></p><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><em>Inherently resistant organisms</em></p><p><strong><em>Aerobic Gram-positive micro-organisms:</em></strong></p><p><em>Corynebacterium jeikium</em></p><p><strong><em>Aerobic Gram-negative micro-organisms:</em></strong></p><p><em>None</em></p><p><strong><em>Other micro-organisms:</em></strong></p><p><em>None</em></p><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Eye :</strong></p><p>CIPROCIN eye drops, solution is rapidly absorbed into the eye following topical ocular administration. Systemic levels are low following topical administration. Plasma levels of ciprofloxacin in human subjects following 2 drops of 0.3% ciprofloxacin solution every 2 hours for two days and then every four hours for 5 days ranged from non-quantifiable (&lt;1.0 ng/mL) to 4.7 ng/mL. The mean peak ciprofloxacin plasma level obtained in this study is approximately 450-fold less than that seen following a single oral dose of 250 mg ciprofloxacin. The systemic pharmacokinetic properties of ciprofloxacin have been well studied. Ciprofloxacin widely distributes to tissues of the body. The apparent volume of distribution at steady state is 1.7 to 5.0 l/kg. Serum protein binding is 20-40%. The half-life of ciprofloxacin in serum is 3-5 hours. Both ciprofloxacin and its four primary metabolites are excreted in urine and faeces. Renal clearance accounts for approximately two-thirds of the total serum clearance with biliary and faecal routes accounting for the remaining percentages. In patients with impaired renal function, the elimination half-life of ciprofloxacin is only moderately increased due to extrarenal routes of elimination. Similarly, in patients with severely reduced liver function the elimination half-life is only slightly longer.</p><p>There are no pharmacokinetic data available in respect of use in children.</p><p>&nbsp;</p><p><strong>Ear :</strong></p><p>The systemic pharmacokinetic properties of ciprofloxacin have been well studied. Ciprofloxacin widely distributes to tissues of the body, with tissue levels typically greater than levels in plasma. The apparent volume of distribution at steady state is 1.7-2.7 l/kg. Serum protein binding is 16 43%. The half life of ciprofloxacin in serum is 3-5 hours. Following oral administration of single doses ranging from 250 to 750 mg to adults with normal renal function, 15-50% of the dose is excreted in urine as unchanged drug and 10-15% as metabolites within 24 hours. Both ciprofloxacin and its four primary metabolites are excreted in urine and faeces. Renal clearance of ciprofloxacin is typically 300-479 ml/minute. Approximately 20-40% of the dose is excreted in faeces as unchanged drug and metabolites within 5 days.</p><p>In children with otitis media with tympanostomy tubes treated with ciprofloxacin 3mg/ml solution (3 drops three times daily for 14 days), plasma concentrations of ciprofloxacin were not detected (limit of quantification 5ng/ml). In children with suppurative otitis with perforated tympanic membrane, treated by ciprofloxacin 2mg/ml solution (twice daily for 7-10 days), no circulating plasma concentration of ciprofloxacin up to the limit of quantification 5ng/ml was detected. No significant systemic passage of ciprofloxacin is expected under the normal conditions of use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, and carcinogenic potential. Non-clinical developmental toxicity was observed only at exposures considered sufficiently in excess of the maximum human exposure, indicating little relevance to clinical use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium Chloride</p><p>Disodium Edetate</p><p>Benzalkonium Chloride Solution</p><p>Water for Injection</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months.
One month after first opening.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep out of the reach and sight of children.</p><p>Store below 30&quot;C. protect from light.</p><p>Keep the bottle tightly closed.</p><p>Stop using the bottle 1 month after first opening to prevent infections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5 ml plastic bottle with white plastic cap and white pilfer proof.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep medicines out of reach &amp; sight of children</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Medical and Cosmetic Products Company Ltd. (Riyadh Pharma)
P.O. Box 442, Riyadh 11411
Fax: +966 11 265 0505
Email: contact@riyadhpharma.com
For any information about this medicinal product, please contact the local representative of marketing authorisation holder:
Saudi Arabia
Marketing department
Riyadh
Tel: +966 11 265 0111
Email: marketing@riyadhpharma.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                09/2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>